Inside the Bell Jar of Social Media: A Descriptive Study Assessing YouTube Coverage of Psychotropic Medication Adherence.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

Original Publication: Basel : MDPI, c2004-

Social Media*; Humans ; Humanities ; Psychotropic Drugs/therapeutic use ; Health Behavior ; Medication Adherence

The global mental health crisis is a longstanding one that impacts a multitude of patient populations worldwide. Within this crisis, psychiatric medication adherence is yet another complex public health challenge that continues to persist and contribute towards the chronic nature of the increased incidence and prevalence of psychiatric morbidities, which in turn result in the sequalae of substantial costs to humanity, the healthcare system, lost productivity, functioning and disability among patients with mental disorders. Psychotropic medication adherence is a significant part of psychiatric care and treatment across severity levels of mental illness. This health behavior is also filled with complexities, given the abundance of social and behavioral determinants as well as intrinsic and extrinsic factors that surround this health behavior. Examining contexts for promoting this health behavior change is crucial in determining directions for addressing it more optimally. There have been several published studies on considerations and interventions to address this health behavior; however, to date, no studies have been published on assessing coverage and directions of content across social media platforms, which trend as a rising health communication medium in our digital era. The present study is the first of its kind to dive into exploring the nature of widely viewed content and deliverers of this content on a prominent social media platform, YouTube, as the basis to determine potential directions for future intervention that can extend to reaching more patients struggling with this high-risk health behavior across the world, given the global reach of social media.

J Clin Med. 2023 May 19;12(10):. (PMID: 37240660)
Front Public Health. 2022 Mar 28;10:818034. (PMID: 35419335)
Front Psychiatry. 2023 Jan 24;14:1136995. (PMID: 36761871)
Br J Clin Pharmacol. 2017 Aug;83(8):1614-1616. (PMID: 28401576)
Mens Sana Monogr. 2013 Jan;11(1):82-99. (PMID: 23678240)
Syst Rev. 2020 Jan 16;9(1):17. (PMID: 31948489)
BMC Psychiatry. 2023 Jan 24;23(1):64. (PMID: 36694142)
Int J Environ Res Public Health. 2022 Dec 14;19(24):. (PMID: 36554679)
Expert Opin Drug Metab Toxicol. 2020 Dec;16(12):1175-1186. (PMID: 32930009)
Psychiatr Serv. 2015 Apr 1;66(4):397-403. (PMID: 25554854)
Gen Hosp Psychiatry. 2020 Jan - Feb;62:28-36. (PMID: 31775066)
Prim Care Companion CNS Disord. 2023 Mar 9;25(2):. (PMID: 36898036)
Stress Health. 2023 May 27;:. (PMID: 37243509)
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):148-159. (PMID: 27487472)
PLoS One. 2023 May 30;18(5):e0286410. (PMID: 37253033)
Health Promot Perspect. 2016 Oct 01;6(4):213-216. (PMID: 27766240)
J Psychiatr Pract. 2020 Jul;26(4):284-293. (PMID: 32692125)
J Health Psychol. 2023 May 28;:13591053231176262. (PMID: 37246408)
Front Pharmacol. 2022 Sep 07;13:967826. (PMID: 36160455)
Int J Environ Res Public Health. 2023 Jan 16;20(2):. (PMID: 36674358)
BMC Psychiatry. 2023 Feb 24;23(1):124. (PMID: 36829184)
Lancet Glob Health. 2020 Nov;8(11):e1352. (PMID: 33069297)
J Affect Disord. 2023 Jul 15;333:403-408. (PMID: 37084972)
Int J Soc Psychiatry. 2017 Dec;63(8):792-795. (PMID: 29145793)
BMC Psychiatry. 2022 Nov 15;22(1):705. (PMID: 36380352)
Pharmaceutics. 2022 Dec 02;14(12):. (PMID: 36559190)
J Affect Disord. 2020 Mar 15;265:1-9. (PMID: 31957686)
Health Promot Perspect. 2017 Sep 26;7(4):238-244. (PMID: 29085802)
Braz J Psychiatry. 2021 May-Jun;43(3):229-230. (PMID: 32696808)

Keywords: digital health; psychiatric disorder; psychotropic medication; side effects; stigma; treatment adherence

0 (Psychotropic Drugs)

Date Created: 20230825 Date Completed: 20230828 Latest Revision: 20230908

20240628

PMC10454501

10.3390/ijerph20166578

37623165